@article{79b1be267ffd4bb4a72235162c265ee8,
title = "Prevention of nosocomial infections in critically ill patients with lactoferrin: A randomized, double-blind, placebo-controlled study",
author = "John Muscedere and Maslove, {David M.} and Boyd, {J. Gordon} and Nicole O'Callaghan and Stephanie Sibley and Steven Reynolds and Martin Albert and Richard Hall and Xuran Jiang and Day, {Andrew G.} and Gwyneth Jones and Francois Lamontagne",
note = "Funding Information: 1Department of Critical Care Medicine, Queen{\textquoteright}s University, Kingston, ON, Canada. 2Department of Medicine, University of British Columbia, Vancouver, BC, Canada. 3Department of Biophysiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada. 4Centre de Recherche de l{\textquoteright}H{\^o}pital du Sacr{\'e}-Coeur de Montr{\'e}al, Critical Care and Medicine Departments, Universit{\'e} de Montr{\'e}al, Montr{\'e}al, QC, Canada. 5Department of Critical Care Medicine, Dalhousie University and the Nova Scotia Health Authority, Halifax, NS, Canada. 6Kingston General Hospital, Kingston, ON, Canada. 7Department of Critical Care Medicine, University of Ottawa, Ottawa, ON, Canada. 8Department of Medicine, Universit{\'e} de Sherbrooke, Sherbrooke, QC, Canada. The study was conceptualized by Dr. Muscedere. All authors contributed to the conduct of the study and/or provided input on the article. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal{\textquoteright}s website (http://journals.lww.com/ccmjournal). Supported, in part, by grants from the Lotte and John Hecht Memorial Foundation and South Eastern Academic Medical Association. The bovine lactoferrin was provided by Advanced Orthomolecular Research. The funders did not have any role in the conceptualization, conduct of the study, study analysis, interpretation of the data, or writing of the article. Dr. Muscedere, Dr. Maslove, Dr. Boyd, Ms. O{\textquoteright}Callaghan, Dr. Reynolds, Dr. Hall, and Dr. Jones disclosed off-label product use of lactoferrin for the reduction of nosocomial infections. Dr. Boyd{\textquoteright}s institution received funding from South Eastern Academic Medical Association (SEAMO) Innovation Fund and SEAMO New Clinician Scientist Award, and he received funding from Physician Services Incorporated New Clinician Science Award. Dr. Hall{\textquoteright}s institution received funding from Queen{\textquoteright}s University, Canadian Institutes for Health Research, and GlaxoSmithKline. Mr. Day{\textquoteright}s institution received funding from Queen{\textquoteright}s University Faculty of Health Sciences to Publisher Copyright: Copyright {\textcopyright} 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.",
year = "2018",
doi = "10.1097/CCM.0000000000003294",
language = "English",
volume = "46",
pages = "1450--1456",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "9",
}